dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Richter, J. |
dc.contributor.author | Tryfonos, C. |
dc.contributor.author | Leal Julià, Marc |
dc.contributor.author | Christodoulou, C. |
dc.contributor.author | Bosch Merino, Assumpció |
dc.contributor.author | Kagiava, Alexia |
dc.contributor.author | Sargiannidou, Irene |
dc.date.accessioned | 2022-05-25T05:59:12Z |
dc.date.available | 2022-05-25T05:59:12Z |
dc.date.issued | 2021-11-02 |
dc.identifier.citation | Kagiava A, Richter J, Tryfonos C, Leal-Julià M, Sargiannidou I, Christodoulou C, et al. Efficacy of AAV serotypes to target Schwann cells after intrathecal and intravenous delivery. Sci Rep. 2021 Dec 2;11:23358. |
dc.identifier.issn | 2045-2322 |
dc.identifier.uri | https://hdl.handle.net/11351/7576 |
dc.description | Malalties del sistema nerviós; Biologia i reparació de la mielina; Sistema nerviós perifèric |
dc.description.sponsorship | Generalitat de Catalunya, 2019FI_B2 00061, 2019FI_B2 00061, Fundació la Marató de TV3, 201607.10, Muscular Dystrophy Association, 603003. |
dc.language.iso | eng |
dc.publisher | Nature Research |
dc.relation.ispartofseries | Scientific Reports;11 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mielina - Metabolisme |
dc.subject | Injeccions |
dc.subject | Sistema nerviós - Malalties |
dc.subject.mesh | Schwann Cells |
dc.subject.mesh | /metabolism |
dc.subject.mesh | Injections, Spinal |
dc.subject.mesh | Demyelinating Diseases |
dc.title | Efficacy of AAV serotypes to target Schwann cells after intrathecal and intravenous delivery |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41598-021-02694-1 |
dc.subject.decs | células de Schwann |
dc.subject.decs | /metabolismo |
dc.subject.decs | inyecciones espinales |
dc.subject.decs | enfermedades desmielinizantes |
dc.relation.publishversion | https://doi.org/10.1038/s41598-021-02694-1 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Kagiava A, Sargiannidou I] Neuroscience Department, The Cyprus Institute of Neurology and Genetics and Cyprus School of Molecular Medicine, 1683 Nicosia, Cyprus. [Richter J, Tryfonos C, Christodoulou C] Molecular Virology Department, The Cyprus Institute of Neurology and Genetics and Cyprus School of Molecular Medicine, Nicosia, Cyprus. [Leal-Julià M] Department of Biochemistry and Molecular Biology, Institute of Neurosciences, Barcelona, Spain. Unitat Mixta UAB-VHIR, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Bosch A] Department of Biochemistry and Molecular Biology, Institute of Neurosciences, Barcelona, Spain. Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Bellaterra, Spain. Unitat Mixta UAB-VHIR, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 34857831 |
dc.identifier.wos | 000728529200081 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |